Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Folate analogs" are a broad class of compounds structurally similar to folic acid or its metabolites, designed to interact with the biological pathways dependent on natural folates. These analogs are primarily synthetic (such as methotrexate or pemetrexed) and act by mimicking or inhibiting folate's role in one-carbon metabolism, nucleotide biosynthesis, and cell proliferation. Antifolate drugs function as antimetabolites, predominantly applied in cancer chemotherapy and antimicrobial therapies by targeting key enzymes or transport proteins involved in folate metabolism. The specificity and therapeutic value of a folate analog depends on its affinity for cellular folate carriers and enzymes as well as the tissue context in which it is deployed.
Inhibition of dihydrofolate reductase (DHFR), blocking DNA and RNA synthesis; Inhibition of thymidylate synthase or other folate-dependent enzymes; Competitive binding to folate receptors or transporters as uptake substrates; Antimetabolite action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Folate analog.